News

Christine Hummel Joins Leap as SVP of Manufacturer and Specialty Network Partnerships

Pobryt5x7mBcnXAE Christine Hummel Blog Header 14 image

Leap is growing its leadership team. We're excited to welcome Christine Hummel as Senior Vice President of Manufacturer and Specialty Network Partnerships.

Christine brings more than two decades of healthcare leadership experience spanning pharmaceutical manufacturing, pharmacy services, and specialty distribution, most recently in executive roles at Sanofi, CVS Health, and McKesson. In her new role, she'll lead Leap's strategy and partnerships across pharmaceutical manufacturers and specialty care networks, helping expand access to specialty therapies through more transparent, coordinated care.

"What drew me to Leap is the opportunity to rethink one of the most complex and costly parts of the patient journey through a transparent, clinically focused model," said Christine. "I'm excited to build partnerships that make specialty therapies easier to access while creating value across the healthcare ecosystem."

Her appointment reflects Leap's continued investment in building strong relationships across the specialty drug ecosystem, as the company works with manufacturers, providers, and industry partners to improve access, streamline care, and create value for everyone involved, from employers to patients.

Read the full announcement on Business Wire.

About Leap

Leap makes specialty medicine more affordable and easier to access. Available in all 50 states, Leap supports more than 200 therapies for cancer, multiple sclerosis, rheumatoid arthritis, Crohn's disease, ulcerative colitis, migraine, immunodeficiency disorders, and other complex or chronic illnesses. Every patient is paired with a dedicated, licensed Care Guide, and Leap has earned an industry-leading patient Net Promoter Score of 92.

Share this post

More insights

UzOQy IwMJXtjtGM Our Story image
Education

Why We Started Leap

Leap was founded to solve a problem hiding in plain sight: patients who depend on life-sustaining in...

Read article
agycw6YofJOwHZIu 051926 LEAP PartnerBlocks A 01 01 image
News

Leap Joins the Alight Partner Network

Leap has been named an official partner in the Alight Partner Network, expanding access to transpare...

Read article
aTeI4HNYClf9n8gg LeapHealth Favicon1 image
News

Leap Posts 25x Growth; Expands Executive Team

NEW YORK, NY — February 4, 2026 — Leap, the leading infusion therapy partner for self-funded employe...

Read article
aXvX QIvOtkhCGWz Blog Angle 1648x814 1 image
News

Leap partners with Angle Health to simplify and transform infusion care

Leap has partnered with Angle Health  to make infusion care simpler, more transparent, and less disr...

Read article
aXvX gIvOtkhCGW0 Blog EBN 1648x814 image
Education

Why Specialty Infusion Costs Are Straining Employer Healthcare Budgets

Specialty infusion costs are quietly becoming one of the most significant pressures on employer heal...

Read article
aVrZqHNYClf9oxFn Leap InfusionCostCrisisHero image
Education

The Infusion Cost Crisis: Why Medical Benefit Drug Spend Keeps Escalating

For employers, however, infusion care has quietly become one of the fastest-growing and least unders...

Read article
aVtRHXNYClf9oxSu Background image
News

Leap Joins the Castlight Ecosystem to Simplify Infusion Care

Leap has joined the Castlight ecosystem to give TPAs and employers a more transparent, predictable, ...

Read article
aVsOVXNYClf9oxMj Leap Acronyms image
Education

Demystifying Specialty Drug Pricing Acronyms, and Why They All Fail Employers

Behind the exorbitant costs of infusion therapies, you’ll find layers of complexity—and three acrony...

Read article
aVsRYHNYClf9oxNS Leap Rebates image
Insights

Rebates, what rebates? Understanding pharmacy rebates for J-Code drugs

Pharmacy rebates are manufacturer-paid discounts, typically negotiated behind

Read article
aVr8AXNYClf9oxKq Leap HomeInfusion 2 image
Clinical

Safely Infusing Immunoglobulin in the Home Setting: Clinical Considerations and Best Practices

Immunoglobulin (Ig) therapies are essential in the treatment of primary immunodeficiency (PID), chro...

Read article